Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
Authors:
- 16 August 2024
- journal article
- research article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 82 (4) , 3157-3208
Abstract
Despite the waning of traditional treatments for glioma due to possible long-term issues, the healing possibilities of substances derived from nature have been reignited in the scientific community. These natural substances, commonly found in fruits and vegetables, are considered potential alternatives to pharmaceuticals, as they have been shown in prior research to impact pathways surrounding cancer progression, metastases, invasion, and resistance. This review will explore the supposed molecular mechanisms of different natural components, such as berberine, curcumin, coffee, resveratrol, epigallocatechin-3-gallate, quercetin, tanshinone, silymarin, coumarin, and lycopene, concerning glioma treatment. While the benefits of a balanced diet containing these compounds are widely recognized, there is considerable scope for investigating the efficacy of these natural products in treating glioma.Keywords
This publication has 620 references indexed in Scilit:
- The effects of thymoquinone and quercetin on the toxicity of acrylamide in rat glioma cellsJournal of Biochemical and Molecular Toxicology, 2022
- Epigallocatechin‐3‐gallate induces telomere shortening and clastogenic damage in glioblastoma cellsEnvironmental and Molecular Mutagenesis, 2019
- Curcumin changes the polarity of tumor‐associated microglia and eliminates glioblastomaInternational Journal of Cancer, 2016
- MicroRNA‐378 inhibits cell growth and enhances l‐OHP‐induced apoptosis in human colorectal cancerIUBMB Life, 2014
- Coupling to a glioblastoma-directed antibody potentiates antitumor activity of curcuminInternational Journal of Cancer, 2013
- Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27Cancer, 2010
- Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytesCancer, 2009
- Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancerInternational Journal of Cancer, 2003
- Amplification and overexpression of theAKT2 oncogene in a subset of human pancreatic ductal adenocarcinomasMolecular Carcinogenesis, 1998
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995